CT findings of mycoplasma pneumoniae pneumonia in children
10.13929/j.issn.1672-8475.2024.12.008
- VernacularTitle:儿童肺炎支原体肺炎CT表现
- Author:
Jianhui FAN
1
;
Min LIU
;
Jianping WANG
;
Yifei NI
;
Anqi LIU
;
Haoyu YANG
;
Binghuai LU
Author Information
1. 云南省第一人民医院昆明理工大学附属医院放射科,云南 昆明 650032
- Publication Type:Journal Article
- Keywords:
child;
mycoplasma pneumonia;
tomography,X-ray computed
- From:
Chinese Journal of Interventional Imaging and Therapy
2024;21(12):762-766
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe CT findings of mycoplasma pneumoniae pneumonia(MPP)in children.Methods A total of 85 MPP children confirmed by mycoplasma pneumoniae nucleic acid test were retrospectively collected.Chest CT manifestations of MPP were analyzed,and artificial intelligence pneumonia CT image-assisted diagnostic analysis software was used to quantify lesion volume(LV),percentage of lesion LV in total lung volume(LV%)and CT value,and the correlations of quantitative CT parameters with clinical laboratory indicators were explored.Results The main CT manifestations of MPP in children included thickened bronchial wall(78/85,91.76%),tree bud sign(70/85,82.35%),large mass compaction(39/85,45.88%),bronchial occlusion(29/85,34.12%),air bronchial sign(25/85,29.41%),acinar nodules(23/85,27.06%),consolidation along the bronchus(21/85,24.71%),cotton ball sign(19/85,22.35%),tree fog sign(15/85,17.65%)and atelectasis(14/85,16.47%).The median LV of MPP was 50.73(26.38,85.90)cm3,the median LV%was 3.10%(1.60%,5.70%)and the median CT value was-422.61(-479.46,-343.76)HU.MPP LV was positively correlated with serum sialic acid,C reactive protein(CRP),D-dimer,fibrin degradation products(FDP)and fibrinogen(Fib)(rs=0.232-0.400),while LV%was positively correlated with serum sialic acid,D-dimer and FDP(rs=0.349-0.439).There was a positive correlation between CT value and CRP(rs=0.288).Conclusion CT findings of MPP in children had certain characteristics.Combining with laboratory examinations was conducive to clinical diagnosis,monitoring condition and evaluating therapeutic efficacy of MPP in children.